JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB144834

1-Deoxynojirimycin, alpha-glycosidase inhibitor

Be the first to review this product! Submit a review

|

(0 Publication)

MW 163.17 Da, Purity >98%. Potent α-glycosidase inhibitor (IC50 = 30 nM). Antihyperglycemic agent. Downregulates SGLT1, Na+/K+-ATP and GLUT2 expression. Decreases MCP-1 and TNF-α levels. Shows antidiabetic, antiviral, antiobesity and anti-inflammatory effects in vivo. Orally active.

View Alternative Names

4-alpha-glucosidase, 70 kDa lysosomal alpha-glucosidase, Acid Maltase, Acid alpha glucosidase, Aglucosidase Alfa, Alpha glucosidase II alpha subunit, Alpha-glucosidase, Alpha-glucosidase 2, G2AN, GANAB_HUMAN, Glu II, Glucan 1, Glucoamylase, Glucosidase II alpha, Glucosidase II subunit alpha, Glucosidase alpha, Glucosidase alpha acid, Glucosidase alpha acid (Pompe disease glycogen storage disease type II), Glucosidase alpha neutral AB, KIAA0088, LYAG_HUMAN, Lysosomal Alpha-Glucosidase, MGAML, MGA_HUMAN, Maltase-glucoamylase, intestinal, Neutral alpha glucosidase AB precursor, Neutral alpha-glucosidase AB

1 Images
Chemical Structure - 1-Deoxynojirimycin, alpha-glycosidase inhibitor (AB144834)
  • Chemical Structure

Lab

Chemical Structure - 1-Deoxynojirimycin, alpha-glycosidase inhibitor (AB144834)

2D chemical structure image of ab144834, 1-Deoxynojirimycin, alpha-glycosidase inhibitor

Key facts

CAS number

19130-96-2

Purity

>98%

Source

Streptomyces sp.

Molecular weight

163.17 Da

Molecular formula

C<sub>6</sub>H<sub>1</sub><sub>3</sub>NO<sub>4</sub>

PubChem

29435

Nature

Native

Solubility

Soluble in water to 100 mM

Biochemical name

1-Deoxynojirimycin

Biological description

Potent α-glycosidase inhibitor (IC50 = 30 nM). Antihyperglycemic agent. Downregulates SGLT1, Na+/K+-ATP and GLUT2 expression. Decreases MCP-1 and TNF-α levels. Shows antidiabetic, antiviral, antiobesity and anti-inflammatory effects in vivo. Orally active.

Canonical smiles

C1C(C(C(C(N1)CO)O)O)O

Isomeric smiles

C1[C@@H]([C@H]([C@@H]([C@H](N1)CO)O)O)O

InChi

InChI=1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5-,6-/m1/s1

InChiKey

LXBIFEVIBLOUGU-JGWLITMVSA-N

IUPAC Name

(2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GANAB GAA and MGAM are enzymes part of the family known as glycosidases. GANAB also known as glucosidase II alpha subunit has a molecular mass of about 110 kDa and is broadly expressed in the endoplasmic reticulum. GAA or acid alpha-glucosidase weighs around 105 kDa and primarily expresses in lysosomes. MGAM referred to as maltase-glucoamylase shows a molecular mass of approximately 185 kDa concentrating on the small intestine's brush border. These proteins contribute to the breakdown of carbohydrates specifically acting on glycosidic bonds facilitating glucose conversion to provide energy.
Biological function summary

These glycosidase enzymes play essential roles in carbohydrate metabolism. GANAB processing involves the trimming of glucose residues during N-linked glycoprotein maturation. GAA participates in glycogen degradation converting glycogen to glucose in lysosomes. MGAM functioning in the digestive tract helps digest dietary starch into free glucose units. These enzymes operate as part of enzymatic systems ensuring the proper turnover and processing of large carbohydrate molecules critical for cellular and organismal energy management.

Pathways

GANAB GAA and MGAM fit into the glycoside hydrolysis pathway influencing the degradation of complex carbohydrates. GAA's role in glycogenolysis is important for maintaining energy balance in cells linking to the lysosomal degradation pathway alongside the protein LAMP2. MGAM is associated with the digestion pathway impacting nutrient absorption in conjunction with the enzyme sucrase-isomaltase. These pathways underpin the metabolic processes that convert stored and dietary carbohydrates to bioavailable forms of energy.

These enzymes show significant implications for metabolic storage diseases and digestive disorders. GAA is directly related to Pompe disease a lysosomal storage disorder due to deficient glycogen breakdown. In this condition GAA's functionality closely ties to LAMP proteins which support lysosomal integrity. MGAM influences starch digestion-related conditions such as congenital sucrase-isomaltase deficiency where improper starch breakdown affects nutritional absorption. Understanding these enzyme-related pathways opens opportunities for targeted disease therapies and metabolic interventions.

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com